Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism

Journal of Leukocyte Biology

Volumn 67, Issue 6, 2000, Pages 817-824

  Blazevic, V ^a   Pinto, L A ^a   Trubey, C M ^a   Shearer, G M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Costimulatory molecules; CTL; CTLA4Ig; Human

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2;

ANTIGEN RECOGNITION; ARTICLE; CELL CONTACT; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL;

EID: 0033840147     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.67.6.817     Document Type: Article

References (47)

1. The B7 and CD28 receptor families
2. CTLA4Ig: Effects on cellular and humoral immunity and macrophage activation
3. Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation
4. CTLA-4 can function as a negative regulator of T cell activation
5. The emerging role of CTLA-4 as an immune attenuator
6. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens
7. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes
8. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases
9. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
10. Blocking CD40-CD154 and CD80/CD86-CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production
11. + T helper lymphocytes in asymptomatic human immunodeficiency virus infection
12. How T cells recognize alloantigen: Evidence for two pathways of allorecognition
13. Direct gene transfer for the understanding and treatment of human disease
14. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes
15. Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma
16. Control of human melanoma growth in nude mice by autologous allo-activated peripheral blood lymphocytes
17. Allogeneic murine melanoma cell vaccine: A model for the development of human allogeneic cancer vaccine
18. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus
19. Strategies for AIDS vaccines
20. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission
21. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: What mediates protection and why does it develop?
22. A model of the selective loss of major histocompatibility self restricted T cell immune responses during the development of acquired immunodeficiency syndrome (AIDS)
23. Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens
24. Costimulation of T cells for tumor immunity
25. Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity
26. Dysregulation of B7.2 (CD86) expression on monocytes of HIV-infected individuals is associated with altered production of IL-2
27. Virus specificity of human influenza virus-immune cytotoxic T cells
28. + cell suppression of HIV replication
29. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease
30. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes
31. Antigenic variant of swine influenza virus causing proliferative and necrotizing pneumonia in pigs
32. T cell subpopulations required for the human cytotoxic T lymphocyte response to influenza virus: Evidence for T cell help
33. Direct and indirect recognition: The role of MHC antigens in graft rejection
34. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
35. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus
36. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
37. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig
38. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
39. Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation
40. AIDS update 1999: Viral reservoirs and immune-based therapies
41. Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS
42. A Th1 → Th2 switch is a critical step in the etiology of HIV infection
43. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus
44. Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative response: To mitogens, recall antigens and HIV-related antigens
45. Type 1/type 2 cytokine modulation of T-cell programed cell death as a model for human immunodeficiency virus pathogenesis
46. Alloantigen-stimulated anti-HIV activity
47. + T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women